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Q fever is caused by Coxiella burnetii, an obligate
intracellular bacterium, which survives in an
acidic vacuole and escapes killing by preventing
phagosome maturation [1]. In acute Q fever,
granuloma formation is dependent on migration
of leucocytes through the vascular endothelium.
During chronic Q fever, granulomas are lacking
and monocytes do not migrate across the endo-
thelium [1], suggesting that host resistance against
C. burnetii requires innate immune components.
Toll-like receptors (TLRs) are pattern recogni-
tion receptors important in C. burnetii recognition.
Although TLR4) ⁄) and control mice have a
similar pattern of tissue infection and clearance,
granuloma formation and cytokine response are
controlled, in part, by TLR4 [1]. TLR2 is also
involved in granuloma formation but seems
dispensable for bacterial clearance [2]. The obli-
gate intracellular lifestyle of C. burnetii drew
our attention to elucidate the contribution of
another family of proteins implicated in microbial
detection, the cytoplasmic nucleotide-binding
oligomerization domain (Nod) proteins, and
more speciﬁcally Nod2, in innate immunity to
C. burnetii. Nod2 contains leucine-rich repeats
similar to those found in TLRs and is thought to
be responsible for recognition of peptidoglycans
from Gram positive and Gram negative bacteria
through direct or indirect interaction with mura-
myl dipeptide. Nod2 signalling contributes to
inﬂammatory response via activation of the tran-
scription factor NF-jB, which is necessary for
clearing pathogens. The intracellular localisation
of Nod2 and C. burnetii makes Nod2 a potential
candidate for C. burnetii recognition through
leaking into the cytoplasm of muramyl dipep-
tide-containing cell wall fragments.
Bone marrow-derived macrophages (BMDM)
from control and Nod2) ⁄) mice [3] were incu-
bated with C. burnetii for 4 h and cultured for
12 days. Infection was measured by determining
the number of C. burnetii DNA copies as previ-
ously described [2]. Uptake and survival of
C. burnetii in BMDM did not depend on Nod2
as DNA copy number was similar in control and
Nod2) ⁄) BMDM (data not shown).
Next, we tested whether the production of
cytokines ⁄ chemokines by C. burnetii-stimulated
BMDM required Nod2. We assessed the expres-
sion of genes encoding pro-inﬂammatory (TNF)
and immunoregulatory cytokines (IL-10). BMDM
were stimulated for 8 h with C. burnetii and gene
expression was monitored by quantitative RT-
PCR [2]. In Nod2) ⁄) BMDM, although TNF
transcripts were induced, they were signiﬁcantly
reduced compared with control macrophages
(Fig. 1a). This result agrees with other studies
showing that TNF and IL-12p40 levels are
reduced in the absence of Nod2 after stimulation
with Mycobacterium tuberculosis [4]. Note that IL-
10 was not affected by the absence of Nod2
(Fig. 1a). IL-10 is known to interfere with macro-
phage activation by stimulating the replication of
C. burnetii through decreasing TNF production
and blocking phagosomal maturation [1]. IL-10 is
also associated with the chronic evolution of Q
fever [1]. The absence of IL-10 modulation
observed in Nod2) ⁄) BMDM is consistent with
these data, as we did not observe any increase in
bacterial replication. We also measured the
expression of RANTES and MCP-1, two chemo-
kines modulated in response to C. burnetii [5].
RANTES expression was fourfold increased in
Nod2) ⁄) BMDM whereas MCP-1 expression was
decreased by 40% (Fig. 1a). It is likely that
RANTES and MCP-1 play a role in Q
fever pathophysiology, as their production is
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dramatically increased in patients with chronic Q
fever [5].
These data suggest that Nod2 is at least in part
involved in BMDM activation and that Nod2 may
be required for host defence against C. burnetii. We
injected control and Nod2) ⁄) mice with C. burnetii
(5 · 105 organisms) by the intraperitoneal route,
and monitored infection for 49 days. No sign of
morbidity and mortality was observed. Host
response to C. burnetii was assessed by measuring
C. burnetii-speciﬁc circulating antibodies [2], which
reached amaximal value at day 14 post-infection in
control and Nod2) ⁄) mice (Fig. 1b). Course of
tissue infection was assessed by quantitative PCR.
In the spleen from control and Nod2) ⁄) mice
(Fig. 1c), bacterial DNA copies were detectable at
day 4 post-infection and maximal at day 7. In the
liver from wt and Nod2) ⁄) mice, a similar trend
was observed, with a maximal value at day 14
(Fig. 1d). Hence, no difference in bacterial load
was observed, and C. burnetii organisms were
completely cleared after 42 days.
In conclusion, these data suggest that Nod2 is
dispensable for the control of C. burnetii infection.
We cannot rule out synergistic host cell activation
because C. burnetii possesses both TLR and Nod2
agonists. Indeed, TLR2 is required for granuloma
formation while it is dispensable for C. burnetii
clearance [2]. Further studies are required to
address this hypothesis. It may be necessary to
use mice lacking both Nod2 and Nod1, a closely
related cytosolic protein also implicated in bacte-
rial detection, to gain a full picture of C. burnetti
cytoplasmic detection. The mechanism by which
a cytosolic sensor such as Nod2 recognises
phagosome-contained pathogens remains to be
elucidated.
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Fig. 1. Host responses to C. burnetii
infection. (a) BMDM from control
(white bars) and Nod2) ⁄) (black
bars) were infected with C. burnetii
for 8 h and transcripts encoding
TNF, IL-10, RANTES and MCP-1
were quantiﬁed by quantitative RT-
PCR. Results are expressed as the
ratio of expression levels in infected
cells vs. uninfected cells (n = 4). (b, c
and d) Control (white bars) and
Nod2) ⁄) (black bars) mice were
infected and C. burnetii-speciﬁc cir-
culating antibodies were measured
over the course of infection (b).
Bacterial load in the spleen (c) and
in the liver (d) was monitored by
quantitative PCR. *p < 0.005,
**p < 0.0005.
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